Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor and cytokine interactions in shock.

D Hosford1, M Paubert-Braquet, P Braquet

  • 1Institute Henri Beaufour, Le Plessis Robinson, France.

Resuscitation
|December 1, 1989
PubMed
Summary

Platelet-activating factor (PAF) significantly contributes to shock by altering hemodynamics and immune function. PAF antagonists offer protection against shock, potentially by inhibiting PAF-cytokine interactions and exhibiting antiprotease activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies.

European urology·1998
Same author

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils.

Prostaglandins, leukotrienes, and essential fatty acids·1997
Same author

Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.

The Journal of pharmacology and experimental therapeutics·1997
Same author

The relationship between farnesylation and carcinogenesis: the effect of lovastatin on fibroblast proliferation.

Advances in experimental medicine and biology·1997
Same author

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.

Pharmacological research·1996
Same author

Role of platelet activating factor in kidney transplant rejection in the rat.

Kidney international·1995

Area of Science:

  • Immunology
  • Pharmacology
  • Pathophysiology

Background:

  • Shock involves significant hemodynamic changes and immune system impairment.
  • Platelet-activating factor (PAF), an inflammatory mediator, is implicated in shock alongside cytokines.
  • Elevated PAF levels and PAF infusion mimic shock states in animal models.

Purpose of the Study:

  • To explore the role of PAF in shock pathophysiology.
  • To investigate the protective mechanisms of PAF antagonists in shock.

Main Methods:

  • Review of existing studies on PAF and shock in animal models.
  • Analysis of the interaction between PAF and cytokines in traumatic states.

Main Results:

  • PAF infusion replicates shock conditions.

Related Experiment Videos

  • Increased PAF production is observed during shock.
  • PAF antagonists demonstrate protective effects against various forms of shock.

    • Conclusions:

    • PAF plays a critical role in the development of shock.
    • PAF antagonists may counteract shock through antiprotease activity and by inhibiting PAF-cytokine feedback loops.
    • Further research is needed to fully elucidate the protective mechanisms of PAF antagonists.